NEW YORK, Aug. 9 – Academic researchers collaborating with Montreal-based SignalGene have identified a genetic variation that may cut the risk of developing breast cancer by 50 percent, the company said on Thursday. 

Using population genetics to study 716 Caucasian women of French Canadian descent, researchers at Université Laval and several hospitals in Quebec City found two versions of a gene that encode for an androgen receptor.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

A federal grand jury has indicted Elizabeth Holmes and Ramesh Balwani for alleged wire fraud in conjunction with their activities at Theranos.

Nature News reports that some developers are nervous about GitHub's acquisition by Microsoft.

A direct-to-consumer genetic testing company sent out used spit kits, CNBC reports.

In PLOS this week: comparison of commercial bisulfite kits, new method to predict essential proteins, and more